TransAlta to Host Investor Day CALGARY, Alberta, Feb. 27, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) is pleased to announce that it will hold an Investor Day in Toronto on Monday, March 23, 2026. The formal presentation will commence at 9:00 a.m. During the event, we will provide an in-depth overview of the Company’s strategic priorities, long-term plan, financial outlook and growth opportunities. TransAlta’s Investor Day is open to the investment community and is being hosted in a hybrid format, with in-person and live webcast attend...
TransAlta Enters Memorandum of Understanding for Data Centre Development at Keephills Site with Potential to Scale Up to 1 GW CALGARY, Alberta, Feb. 27, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TSX: TA) (NYSE: TAC) (TransAlta or the Company) is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Canada Pension Plan Investment Board (CPP Investments) and Brookfield to advance a data centre development in Alberta, for which TransAlta will be the exclusive site and power provider. The MOU establishes a framework for phased development at the Company'...
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the fourth quarter and full-year ended December 31, 2025. Recent Highlights Generated revenue of $62.5 million in fourth quarter 2025 and revenue of $212.7 million for the full-year 2025, an increase of 2% compared t...
TransAlta Reports Fourth Quarter and Year End 2025 Results, Announces Data Centre Agreement, Declares Dividend Increase and Provides 2026 Outlook CALGARY, Alberta, Feb. 27, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the fourth quarter and year ended Dec. 31, 2025. “TransAlta delivered strong performance in 2025, demonstrating its ability to generate solid free cash flow notwithstanding softer Alberta power prices, subdued market volatility, and lower merchant production. Our hedging strategy and...
OrthoPediatrics to Participate in Upcoming Conferences WARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences. Event: TD Cowen 46th Annual Health Care Conference Format: Fireside Chat Date: Tuesday, March 3, 2026Time: 1:10 pm ET Event: The Citizens Life Sciences Conference Format: Fireside Chat Date: Tuesday, March 10, 2026Time: 10:10 am ET An audio webcast of the ...
Communiqué de presse : Dupixent de Sanofi et Regeneron recommandé pour approbation dans l'UE dans le traitement de l'urticaire chronique spontanée chez les jeunes enfants dont les symptômes persistent malgré un traitement Dupixent de Sanofi et Regeneron recommandé pour approbation dans l'UE dans le traitement de l'urticaire chronique spontanée chez les jeunes enfants dont les symptômes persistent malgré un traitement S’il est approuvé, Dupixent serait le premier médicament ciblé dans l’Union Européenne indiqué chez les enfants âgés de 2 à 11 ans atteints d’UCS insuffisamment contrôlées ...
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged two to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a chronic skin disease with underlying type 2 inflammation that can c...
Notice of the Annual General Meeting of Orrön Energy AB The shareholders of Orrön Energy AB (publ), 556610-8055 (“Orrön Energy” or the “Company”), are hereby given notice of the Annual General Meeting to be held on 1 April 2026 at 11.00 (CEST). The meeting will be held digitally. Shareholders may choose to exercise their voting rights at the Annual General Meeting by attending the digital meeting in person, through a proxy or by postal voting. Vote at the Annual General Meeting Those who wish to exercise their voting rights at the Annual General Meeting must: be entered as a shareholder...
Range Increases Quarterly Dividend By 11% FORT WORTH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the first quarter. A dividend of $0.10 per common share is payable on March 27, 2026 to stockholders of record at the close of business on March 13, 2026. This represents an 11% increase to Range’s quarterly cash dividend and provides an annualized dividend of $0.40 per share. RANGE RESOURCES CORPORATION (NYSE: RRC) is a leading U.S. independent natural ...
Kallelse till årsstämma i Orrön Energy AB Aktieägarna i Orrön Energy AB (publ), 556610-8055, (”Orrön Energy” eller ”Bolaget”) kallas härmed till årsstämma den 1 april 2026, kl. 11.00. Stämman kommer att hållas digitalt. Aktieägare kan välja att utöva sin rösträtt vid den digitala årsstämman genom deltagande personligen, genom ombud eller genom poströstning. Utövande av rösträtt vid årsstämmanDen som önskar utöva sin rösträtt vid årsstämman ska: vara införd som aktieägare i den av Euroclear Sweden AB förda aktieboken den 24 mars 2026 eller, om aktierna är förvaltarregistrerade, begära att...
Gogo Announces Fourth Quarter and Full Year 2025 Results Total Q4 Revenue of $230.6 million, up 67% Year-over-Year; Service Revenue of $191.9 million, up 61% Year-over-Year Full Year Results at High End of 2025 Guidance Range for Revenue, Adjusted EBITDA and Free Cash Flow Gogo Galileo and 5G Expected to Ramp in 2026 Company Provides 2026 Financial Guidance BROOMFIELD, Colo., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ: GOGO) (“Gogo” or the “Company”), a leading global provider of broadband connectivity services for the business and military/government aviation markets, tod...
Boralex et Six Nations of the Grand River Development Corporation mettent en service le plus grand projet de stockage d’énergie par batteries au Canada HAGERSVILLE, Ontario, 27 févr. 2026 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) et son partenaire, Six Nations of the Grand River Development Corporation (« SNGRDC »), annoncent la mise en service commerciale du parc de stockage d’énergie par batteries Hagersville, la plus grande installation de stockage par batteries en exploitation au Canada. Avec une capacité de 300 MW / 1 200 MWh, ce projet d’envergure ...
Boralex and Six Nations of the Grand River Development Corporation Commission Canada’s Largest Operating Battery Storage Facility HAGERSVILLE, Ontario, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex”) (TSX: BLX) and Six Nations of the Grand River Development Corporation (SNGRDC) announce the commercial commissioning of the Hagersville Battery Energy Storage Park, the largest operating battery energy storage facility in Canada. With a capacity of 300 MW / 1,200 MWh, the landmark project represents a significant milestone in Ontario’s energy transition and positions SNGRDC and Bor...
Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging MELBOURNE, Australia and INDIANAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a research collaboration with University Hospital Essen on the PROMISE-PET registry1, defining the potential prognostic value of PSMA-PET2 imaging through artificial intelligence (AI). PROMISE (PROstate cancer Molecular Imaging Standardized Evaluation)-PET is a multi-center, prospective, observational, non-in...
Enwex Netherlands, France and Spain Wind Futures Now Live for Trading on Abaxx Exchange Providing standardized tools to hedge wind generation risk across Europe’s leading renewable markets TORONTO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Po...
OTC Markets Group Welcomes RUA GOLD INC. to OTCQX NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (TSX: RUA; OTCQX: NZAUF), an exploration company, has qualified to trade on the OTCQX® Best Market. RUA GOLD INC. upgraded to OTCQX from the OTCQB® Venture Market. RUA GOLD INC. begins trading today on OTCQX under the symbol “NZAUF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . The OTCQX Market is designed for established,...
Brunswick Exploration Announces Appointment of Vice President – International Projects MONTREAL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (, ; ; “BRW” or the “Company”) is pleased to announce the appointment of Charles Kodors to Vice President – International Projects. Mr. Kodors has been with Brunswick Exploration since its rebranding in 2020 and has been instrumental in securing the Company’s international portfolio over the last three years. Mr. Killian Charles, President and CEO of BRW, commented: “Charles is a key part of Brunswick’s exploration team alongside Fr...
Brunswick Exploration Files Maiden Mineral Resource Estimate NI 43-101 Technical Report for Mirage Project MONTREAL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (, ; ; “BRW” or the “Company”) is pleased to announce that it has filed on SEDAR the “NI 43-101 Technical Report for the Mirage Maiden Mineral Resource Estimate, Eeyou Istchee James Bay, Quebec, Canada”, with an effective date of January 7, 2026. The Mineral Resource Estimate (“MRE”) was prepared in accordance with the National Instrument (“NI”) 43-101 standards by PLR Resource Inc. and Synectiq Inc. The full tec...
Aurora Mobile Partners with China Post Securities to Deliver Millisecond Messaging and Enhance Digital Financial Services SHENZHEN, China, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, today announced a strategic partnership with China Post Securities. By integrating Aurora Mobile’s intelligent push notification solution, JPush, the two companies have built a financial-grade messaging infrastructure to improve the speed, stability, and accuracy of digital financi...
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a chronic skin disease with underlying type 2 inflammation that can cause debilitating hives and recurring itch in young children TARRYTOWN, N.Y. and PARIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.